Vironova´s CEO Mohammed Homman earlier this week at SwedenBIO Hack and The Swedish Drug Discovery and Development Pipeline Report 2020 release. Presenting the status of Sweden’s drug development projects in clinical and pre-clinical phases.
Finding critical quality parameters using TEM-based image analysis
Currently no scheduled events
Contact
Vironova AB
Gävlegatan 22
113 30 Stockholm
SWEDEN
E-mail: info@vironova.com